Transcript of the earnings conference call on financial results for the quarter ended December 31, 2025
INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indegene has submitted the transcript of its earnings conference call held to discuss financial results for the quarter ended December 31, 2025 (Q3 FY26). This is a routine post-earnings regulatory disclosure filed with the stock exchanges. The transcript typically contains management commentary on quarterly performance, segment updates, deal pipeline, and forward guidance, along with analyst Q&A. The actual transcript content is hosted on the exchanges' website and would need to be reviewed separately for specific data points and guidance details.
Neutral filing on its own — the stock reaction depends on what management said during the call regarding margins, growth outlook, and any forward guidance. Investors should read the transcript directly for actionable insights.